New MRI method may spare kidney patients unnecessary biopsies

NCT ID NCT06126159

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special MRI can tell the difference between harmless and cancerous kidney growths when standard CT scans cannot see fat. About 44 adults with kidney masses that have no visible fat on CT will get this advanced MRI. The goal is to see if the MRI can identify tumor types and guide treatment without needing a needle biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

multiparametric and fat-detection magnetic resonance imaging (MRI)

What this could lead to

If successful, this MRI method could help doctors diagnose kidney tumor types without needing a biopsy, guiding treatment decisions more safely.

What could go wrong

This is a small, early-stage study with only 44 participants, so results may not apply to everyone. The MRI technique may not be accurate enough to replace biopsy in all cases.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

angiomyolipoma kidney cancer kidney neoplasm renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Li-Jen Wang

    Taoyuan, Taiwan, 333, Taiwan